O que há de novo

Notícias

Novo anúncio de conscientização AFTD será exibido em 20 de outubro no New York Times

On October 20, the Sunday print edition of the New York Times will feature the latest in…

Leia mais >

Target ALS and AFTD Partner to Spur Drug and Biomarker Development for ALS and FTD

Today, AFTD and Target ALS have announced a groundbreaking partnership and call for proposals to identify treatments…

Leia mais >

A perspectiva de um parceiro de cuidados: a importância da advocacia

Partners in FTD Care Fall 2019 In her late 40s, Donna, a research chemist/geologist began acting differently….

Leia mais >

Preparando-se para falar com o médico

Partners in FTD Care Fall 2019 Effective pharmacological management of FTD depends on careful, ongoing observation of…

Leia mais >

Uma visão geral dos medicamentos usados na FTD

Partners in FTD Care Fall 2019 By Deborah Reed, MD, Guest Contributor Currently there are no FDA-approved…

Leia mais >

O que fazer sobre… Medicamentos para sintomas de FTD

Partners in FTD Care Fall 2019 While healthcare providers’ understanding of FTD is increasing, persons diagnosed and…

Leia mais >

Apenas parte da resposta: Medicamentos e FTD

Partners in FTD Care, Fall 2019 Download the full issue (pdf) Frontotemporal degeneration is clinically and biologically…

Leia mais >

“60 Minutes” Brings FTD Awareness to Millions of TV Viewers

On May 5, the venerable CBS news program 60 Minutes aired a segment on FTD, bringing newfound…

Leia mais >

Mais de 600 Takes na Conferência AFTD 2019

Held on May 3 in Los Angeles, AFTD’s 2019 Annual Education Conference provided the latest developments in…

Leia mais >

AFTD anuncia destinatários de bolsas de pós-doutorado 2019-2021

By supporting talented young investigators during the final stage of their scientific training, AFTD Postdoctoral Fellowships lay…

Leia mais >